During the past decade, Internistische und rheumatologische Praxis Gladbeck conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Internistische und rheumatologische Praxis Gladbeck" #1 collaborator was "Ruhr University of Bochum" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Internistische und rheumatologische Praxis Gladbeck" are "External Causes of Morbidity and Mortality" (1 trials) and "Progression of Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Internistische und rheumatologische Praxis Gladbeck" in a lesser frequency.

Most popular intervention types in "Internistische und rheumatologische Praxis Gladbeck" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials) and "Prednisolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Internistische und rheumatologische Praxis Gladbeck" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Internistische und rheumatologische Praxis Gladbeck". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Internistische und rheumatologische Praxis Gladbeck, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Internistische und rheumatologische Praxis Gladbeck, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".